IM Cannabis (IMCC) Non-Current Assets (2019 - 2026)
IM Cannabis' (IMCC) quarterly Non-Current Assets came in at $6.3 million in Q1 2026, down 41.74% year-on-year from $10.7 million in Q1 2025, and down 2.97% quarter-over-quarter from $6.5 million in Q4 2025.
IM Cannabis (IMCC) Non-Current Assets (2019 - 2026) Analysis & Trends
IM Cannabis' Non-Current Assets history runs 8 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 41.74% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 41.74% decrease from a year earlier, with the FY2025 full-year figure at $6.5 million, down 44.19% from the prior year.
- Non-Current Assets retreated to $6.3 million in Q1 2026 per IMCC's latest filing, from $6.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $158.1 million in Q1 2022 and bottomed at $6.3 million in Q1 2026.
- The 5-year median for Non-Current Assets is $15.7 million (2024), against an average of $30.9 million.
- Across the five-year window, Non-Current Assets jumped 78.01% in 2022 and slumped 87.47% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $20.6 million in 2022, then fell by 12.6% to $18.0 million in 2023, then tumbled by 37.18% to $11.3 million in 2024, then plunged by 43.06% to $6.5 million in 2025, then fell by 2.97% to $6.3 million in 2026.
- Per Business Quant, the three latest IMCC Non-Current Assets figures stand at $6.3 million (Q1 2026), $6.5 million (Q4 2025), and $9.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 6.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | 6.45 Mn |
| Sep 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 11.28 Mn |
| Mar 31, 2025 | 10.74 Mn |
| Dec 31, 2024 | 11.33 Mn |
| Sep 30, 2024 | 12.46 Mn |
| Jun 30, 2024 | 12.63 Mn |
| Mar 31, 2024 | 15.69 Mn |
| Dec 31, 2023 | 18.03 Mn |
| Sep 30, 2023 | 17.92 Mn |
| Jun 30, 2023 | 18.87 Mn |
| Mar 31, 2023 | 20.10 Mn |
| Dec 31, 2022 | 20.63 Mn |
| Sep 30, 2022 | 24.92 Mn |
| Jun 30, 2022 | 150.58 Mn |
| Mar 31, 2022 | 158.14 Mn |
| Dec 31, 2021 | 163.59 Mn |
| Sep 30, 2021 | 157.40 Mn |
| Jun 30, 2021 | 96.67 Mn |